Epidural and Intrathecal Ketamine in Clinical Use

Epidural and intrathecal ketamine refers to injecting ketamine directly into the spinal region, either the epidural space (outside the dura mater, the tough membrane covering the spinal cord) or the intrathecal space (inside the dura, where cerebrospinal fluid circulates). This is a specialized technique used almost exclusively in anesthesiology and pain medicine, typically as an adjunct to local anesthetics or opioids for surgical and chronic pain, not as a route for treating depression or other psychiatric conditions. No formulation of ketamine is FDA-approved for epidural or intrathecal use, so this remains an off-label application performed only by trained physicians in monitored clinical settings.

Epidural vs. Intrathecal: What the Terms Mean

The epidural space sits just outside the dura mater, the membrane that encloses the spinal cord and cerebrospinal fluid (CSF). Anesthesiologists commonly use this space for labor analgesia and some surgical pain control by threading a thin catheter into it. The intrathecal (or spinal) space is deeper, inside the dura, in direct contact with CSF and the spinal cord itself. A single intrathecal injection acts faster and at a lower dose than an epidural one because the drug bypasses the dural barrier entirely.

Both are distinct from the routes covered elsewhere on this site for psychiatric ketamine use, including intravenous (IV), intramuscular (IM), sublingual, intranasal, and oral administration. For a broader comparison of how those routes differ in speed and absorption, see ketamine onset time by route of administration. Two other under-the-skin options sometimes confused with neuraxial dosing are covered in subcutaneous ketamine administration clinical use and buccal ketamine administration absorption and clinical use.

Why Ketamine Is Studied at the Spinal Level

Ketamine is an NMDA (N-methyl-D-aspartate) receptor antagonist, meaning it blocks a glutamate receptor involved in pain signal amplification. In the dorsal horn of the spinal cord, the first relay station for pain signals traveling from the body to the brain, repeated pain input can trigger "central sensitization," a state where the spinal cord becomes hypersensitive to further stimulation. Because NMDA receptors sit at that relay point, researchers have investigated whether adding ketamine directly to epidural or intrathecal local anesthetic-opioid mixtures might blunt this amplification and reduce postoperative or chronic pain more than local anesthetics or opioids alone.

This mechanism is separate from the reasoning behind ketamine's psychiatric use, which involves rapid changes in glutamate signaling and downstream effects such as brain-derived neurotrophic factor (BDNF) activity in mood-related brain circuits. You can read more about that mechanism in the BDNF glossary entry and the complete guide to ketamine.

How This Differs From Ketamine for Depression

If you're researching ketamine for a mental health condition, epidural and intrathecal administration is not a route you're likely to encounter. Psychiatric ketamine treatment, whether generic ketamine given off-label or esketamine (Spravato), the only ketamine-related medication with FDA approval, for treatment-resistant depression, is delivered by IV, IM, sublingual/intranasal, or oral routes in outpatient psychiatric or infusion settings. You can compare two of the most common psychiatric routes in IV ketamine vs. oral ketamine, and read about esketamine specifically on the esketamine (Spravato) page.

Epidural and intrathecal ketamine, by contrast, sits within surgical and pain-management medicine. It's typically discussed alongside other perioperative analgesia techniques, not as an option a patient would choose when comparing depression treatment routes.

Evidence Quality and Safety Context

Research on epidural and intrathecal ketamine consists mostly of small randomized trials, case series, and animal studies rather than large-scale trials, so conclusions about its benefit and long-term safety remain provisional. Side effects reported in this literature include the dissociative effects associated with ketamine generally, you can read more about that experience in understanding dissociation, along with procedural risks inherent to any epidural or spinal injection, such as infection or nerve irritation at the injection site. For a broader rundown of ketamine's side-effect profile across routes, see safety and side effects. If you want to evaluate the underlying studies yourselfhow to read ketamine depression research studies walks through how to weigh study size, design, and dosing when interpreting ketamine research generally.

This article is educational and does not constitute medical advice. Epidural and intrathecal ketamine is a clinical decision made between a patient and their anesthesiologist or pain specialist, based on the specific procedure, condition, and available evidence, not something to pursue outside that supervised setting.